Search

Recent Articles

IJMPO—A Journey of a Thousand Miles

Author : Padmaj S. Kulkarni

Coronavirus Disease 2019 Treatment—T-Cells Hold the Key in Severe Cases

Author : Kunal Das, Nitika Agrawal, Mansi Kala, Rakhee Khanduri

Why Is China Importing COVID-19 Vaccine Now?

Author : Purvish M. Parikh

“PALLCARE Seva”—A Beacon Amid the Catastrophic COVID-19 Times: Correspondence

CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(04): 449-450

DOI: DOI: 10.1055/s-0042-1760319

Dear Editor,

We would like to comment on the publication “‘PALLCARE Seva’—A Beacon Amid the Catastrophic COVID-19 Times: A Cross-Sectional Study from a Rural Oncology Institute in Western Maharashtra[1].” This study reports on an audit of the “PALLCARE Seva” telephone service calls.[1] General practitioners might be consulted in more than one-tenth of cases, according to Patil et al. The main tenets of our service were courtesy and compassion, helpfulness, addressing skepticism about the condition, and giving patients and caregivers a chance to express their ideas. The majority of callers—more than three-fourths—rated their interactions as positive and said they would suggest this service to other patients in need.[1]

We both agree that the coronavirus disease 2019 (COVID-19) outbreak made the switch to broad service necessary. Utilizing a communication tool could be beneficial. However, the scenario in which it is appropriate varies. Poor infrastructure makes it challenging to access IT or a basic phone in many rural areas of developing nations. As a result, it is necessary to analyze the effectiveness of telephone conversations in light of the regional context. Furthermore, COVID-19's situation is constantly changing. The arrival of a new COVID-19 vaccination and the emergence of a new variation can both have a big impact on the local situation. The shifting local COVID-19 epidemic scenario must be taken into consideration while assessing the effectiveness of phone calls.

Trial Registration

Not applicable.


Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.




Publication History

Article published online:
10 February 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Dear Editor,

We would like to comment on the publication “‘PALLCARE Seva’—A Beacon Amid the Catastrophic COVID-19 Times: A Cross-Sectional Study from a Rural Oncology Institute in Western Maharashtra[1].” This study reports on an audit of the “PALLCARE Seva” telephone service calls.[1] General practitioners might be consulted in more than one-tenth of cases, according to Patil et al. The main tenets of our service were courtesy and compassion, helpfulness, addressing skepticism about the condition, and giving patients and caregivers a chance to express their ideas. The majority of callers—more than three-fourths—rated their interactions as positive and said they would suggest this service to other patients in need.[1]

We both agree that the coronavirus disease 2019 (COVID-19) outbreak made the switch to broad service necessary. Utilizing a communication tool could be beneficial. However, the scenario in which it is appropriate varies. Poor infrastructure makes it challenging to access IT or a basic phone in many rural areas of developing nations. As a result, it is necessary to analyze the effectiveness of telephone conversations in light of the regional context. Furthermore, COVID-19's situation is constantly changing. The arrival of a new COVID-19 vaccination and the emergence of a new variation can both have a big impact on the local situation. The shifting local COVID-19 epidemic scenario must be taken into consideration while assessing the effectiveness of phone calls.


#

Conflict of Interest

None declared.

Trial Registration

Not applicable.


Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.


    References

  1.  Patil CR, Tanawade P, Dhamne N, Anap Y, Watve P. “PALLCARE Seva”—A Beacon amid the catastrophic COVID-19 times: a cross-sectional study from a rural oncology institute in western Maharashtra. Indian J Med Paediatr Oncol 2022; 43 (04) 369-375

Address for correspondence

Rujittika Mungmunpuntipantip, PhD, Private Academic Consultant
Bangkok 10203032
Thailand   


Publication History

Article published online:
10 February 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India


We recommend

  1. “PALLCARE Seva”—A Beacon Amid the Catastrophic COVID-19 Times: A Cross-Sectional Study from a Rural Oncology Institute in Western Maharashtra
    Chaitanya R. Patil et al., VCOT Open, 2022
  2. Catastrophic Concomitant Arterial and Venous Thrombosis in a Mild COVID-19-Positive Patient
    Raka A. Nugraha et al., International Journal of Angiology, 2021
  3. Management of a diagnostic radiology department amid Coronavirus disease-19 (COVID-19) pandemic
    Arshed H Parry et al., Indian J Radiol Imaging, 2021
  4. Covid-19 and Pregnancy: An Overview
    Pedro Castro et al., RBGO Gynecology and Obstetrics, 2020
  5. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
    Emmanuel J. Favaloro et al., Seminars in Thrombosis and Hemostasis, 2021

    References

  1.  Patil CR, Tanawade P, Dhamne N, Anap Y, Watve P. “PALLCARE Seva”—A Beacon amid the catastrophic COVID-19 times: a cross-sectional study from a rural oncology institute in western Maharashtra. Indian J Med Paediatr Oncol 2022; 43 (04) 369-375